| Financial Year |
March 31 2023 |
| Monetary Funds |
321,440,916.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,989,930.18 |
| Accounts Receivable |
210,121,601.39 |
| Advances to Suppliers |
15,062,827.01 |
| Other Receivables |
21,503,403.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
228,435,231.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,432,622.77 |
| Total Current Assets |
835,172,739.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
221,512,506.94 |
| Under-construction Projects |
50,459,097.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,881,575.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,333.16 |
| Deferred Income Tax Assets |
20,451,611.53 |
| Other Non-Current Assets |
18,980,198.29 |
| Sub-Total of Non-Current Assets |
410,310,323.50 |
| Total Assets |
1,245,483,063.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
34,396,886.70 |
| Accounts Payable |
67,106,237.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,642,316.01 |
| Taxes Payable |
-2,466,119.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,229,760.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,240,175.66 |
| Other Current Liabilities |
17,028,189.07 |
| Sub-Total of Current Liabilities |
237,832,588.98 |
| Long-term Loans |
9,240,175.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,930,687.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,414,659.02 |
| Total Liabilities |
260,247,248.00 |
| Paid-In Capital(Or Share Stock) |
93,559,091.00 |
| Capital Surplus |
392,662,253.44 |
| Surplus Reserve |
46,779,545.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
428,018,681.11 |
| Minority Stockholder's Interest |
7,456,445.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
977,779,369.15 |
| Owner's Equity（Stockholder's Equity） |
985,235,815.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,245,483,063.05 |
